# Pharmacokinetic and Biomarker Study of Pioglitazone in Adolescents With Severe Sepsis and Septic Shock

> **NCT01352182** · PHASE1,PHASE2 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 12 (actual)

## Conditions studied

- Severe Sepsis
- Septic Shock

## Interventions

- **DRUG:** Pioglitazone hydrochloride

## Key facts

- **NCT ID:** NCT01352182
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2016-05
- **Final completion:** 2017-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01352182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01352182, "Pharmacokinetic and Biomarker Study of Pioglitazone in Adolescents With Severe Sepsis and Septic Shock". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01352182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*